glp 1 agonist in pregnancy Obstetrics & Gynecology | “With rising obesity rates and increasing glucagon-like peptide-1 receptor (GLP-1 RA) use, understanding perinatal prescribing New developments in GLP-1 agonist

Overview of Diabetes Treatment [3]

According to NICE guideline NG238, atorvastatin 20mg is recommended for primary prevention, with higher doses (atorvastatin 80mg or rosuvastatin 2040mg) for secondary prevention

NF-B and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells

16 Nonetheless, other GLP-1 RAs such as albiglutide has also shown reductions on MACE risk up to 22% as demonstrated by the HARMONY trial

In the periphery, posttranslational processing of preproglucagon in the alpha-cells of the pancreas produces glucagon and a small amount of GLP-1 whereas the main source of peripheral GLP-1 production occurs through the posttranslational processing of preproglucagon in the L-cells of the gut (reviewed in Holst, 2007 and Campbell and Drucker, 1992